|
BUB3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.921600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.075600E-01 |
| Normal-vs-Stage2 |
5.048200E-01 |
| Normal-vs-Stage3 |
4.585000E-01 |
| Normal-vs-Stage4 |
1.453790E-01 |
| Stage1-vs-Stage2 |
2.189400E-01 |
| Stage1-vs-Stage3 |
1.580430E-01 |
| Stage1-vs-Stage4 |
1.481960E-01 |
| Stage2-vs-Stage3 |
9.849600E-01 |
| Stage2-vs-Stage4 |
6.702800E-01 |
| Stage3-vs-Stage4 |
6.946800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.319800E-01 |
| Normal-vs-AfricanAmerican |
5.015400E-01 |
| Normal-vs-Asian |
5.583800E-01 |
| Caucasian-vs-AfricanAmerican |
1.958810E-01 |
| Caucasian-vs-Asian |
3.991200E-01 |
| AfricanAmerican-vs-Asian |
6.828600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.268800E-01 |
| Normal-vs-Female |
4.213800E-02 |
| Male-vs-Female |
1.037590E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.747600E-01 |
| Normal-vs-Extreme_Weight |
1.745990E-01 |
| Normal-vs-Obese |
6.818600E-01 |
| Normal-vs-Extreme_Obese |
5.648100E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.272800E-01 |
| Normal_Weight-vs-Obese |
4.475400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.798980E-01 |
| Extreme_Weight-vs-Obese |
5.243700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.628400E-01 |
| Obese-vs-Extreme_Obese |
9.725700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.484400E-02 |
| Normal-vs-Age(41-60Yrs) |
6.413200E-01 |
| Normal-vs-Age(61-80Yrs) |
2.996200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.027500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.594400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.062700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.188800E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.611700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.439800E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.310300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.479400E-01 |
| Normal-VS-Type2 PRCC |
5.018000E-02 |
| Normal-VS-KIRP CIMP |
4.995400E-04 |
| Normal-VS-Unclassified PRCC |
9.283800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.128100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.07039965569334E-10 |
| Type1 PRCC-VS-Unclassified PRCC |
7.278200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.00270039335737E-10 |
| Type2 PRCC-VS-Unclassified PRCC |
7.716200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.9289999999561E-06 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.012400E-01 |
| Normal-vs-N1 |
5.228400E-02 |
| Normal-vs-N2 |
9.765800E-01 |
| N0-vs-N1 |
3.818100E-03 |
| N0-vs-N2 |
7.231000E-01 |
| N1-vs-N2 |
3.926400E-01 |
|
|
